Richard Schasfoort

CSO Vysens

Seminars

Wednesday 9th December 2026
Multi-specific Engagement Studies with World’s First Cell Avidity SPR Imaging Platform: the CellVysion
2:50 pm
  • Avidity driven binding on tumors with multispecific T-cell engagers
  • Tipping point measurements of cell capture under controlled shear conditions
  • KD analysis of biomolecular interactions on cell-receptors in solution
  • Label free determination of the number of specific receptors per cell
Richard Schasfoort - speaker for 2nd T-Cell Engager Therapeutics Summit Europe